Elbracht, M
Decreased endothelial APT1 enzyme activity in diabetic patients suggests its involvement in diabetes progression
Worthington HV, Hunt LP, McCloy RF, Maclennan I, Braganza JM
"Patients who combine medication with consistent lifestyle changesrather than relying on pharmacology aloneare more likely to achieve and maintain substantial, long-term health improvements." Nutrient intake is another thing to consider when starting GLP-1s
Choose semaglutide if: Cost is the primary barrier, you have cardiovascular disease and need the SELECT trial CV evidence behind your treatment, or you respond well to GLP-1 therapy alone
The first senolytic agents, which are drugs that eliminate senescent cells, were discovered through a hypothesis-driven approach